Results
Revise Search
-
Filters:
- "BR2019-05" OR "PD19-02" OR "PD19-01" OR "BR2018-15" OR "BR2018-13" OR "BR2018-04" OR "PD18-01" OR "GC17-06" OR "BR2017-05" OR "BR2017-15" OR "GC16-30" OR "BR2016-04" OR "PD15-06" OR "BR2015-02" OR "GC14-55" OR "BR2014-12" OR "BR2014-04" OR "BR2014-03" OR "BR2014-02" OR "GC12-72"
- 2017
- 2016
- Health care and patient safety
- Health human resources
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
CMA submission to the study of Bill C-37
https://policybase.cma.ca/en/permalink/policy13617
- Date
- 2017-04-06
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
1 document
Consultation on the prescription drug list: Naloxone
https://policybase.cma.ca/en/permalink/policy11847
- Date
- 2016-03-17
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Association. Policy Document PD15-06 - Harms associated with opioids and other
psychoactive prescriptions
1 document
Non-prescription availability of low-dose codeine products
https://policybase.cma.ca/en/permalink/policy13734
- Date
- 2017-11-7
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
1 document
Physician health
https://policybase.cma.ca/en/permalink/policy13739
- Date
- 2017-10-21
- Topics
- Health human resources
- Ethics and medical professionalism
3 documents
- Policy Type
- Policy document
- Date
- 2017-10-21
- Replaces
- PD98-04 Physician health and well-being
Documents
Statement to the House of Commons Committee on Health addressing the opioid crisis in Canada
https://policybase.cma.ca/en/permalink/policy13936
- Date
- 2016-10-18
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
- Health care and patient safety
1 document
- Policy Type
- Parliamentary submission
- Date
- 2016-10-18
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
- Health care and patient safety
Documents
